+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gene Synthesis Market By Method, By Service Type, By Application, By End User, By Regional Outlook, Industry Analysis Report and Forecast, 2021-2027

  • PDF Icon

    Report

  • 275 Pages
  • January 2022
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5552972
The Global Gene Synthesis Market size is expected to reach $5.2 billion by 2027, rising at a market growth of 17.9% CAGR during the forecast period.

Gene synthesis is the process of developing or generating artificial genes through scientific processes. In addition, Gene synthesis refers to the process in which genes are developed through various methods intending to assemble and construct genes from the nucleotide. A nucleotide is a basic and fundamental block in the process of building nucleic acid.

In fact, RNA and DNA are formed by long chains of nucleotides. These substances consist of sugar molecules attached to a group of phosphate and a base that contains nitrogen. The Gene synthesis process allows the scientist and researchers to specify and personalize the desired sequence directly.

The number of research and development in genomics and advanced sequencing is rapidly rising and carries the potentials to enhance the future of the gene synthesis market. Also, the rising scale of investments and funding by the government is expected to also develop the field of gene synthesis. 

Artificial gene synthesis, which is also called DNA synthesis, is a different form of Gene synthesis. The DNA synthesis in living cells occurs when gene molecules get synthesized by all living cells through a process of DNA replication. 

DNA replication is a process in which a double-stranded gene molecule is copied with the purpose to make two similar DNA molecules. Unlike the natural gene synthesis procedure, artificial gene synthesis does not need any template to copy DNA molecules. Instead, it allows any virtually developed DNA sequence to be synthesized.



COVID-19 Impact Analysis


Due to the COVID-19 outbreak, economies across the world were greatly slammed. Various industries were shut due to the government protocols that were applied to restrict the spread of the coronavirus. During the lockdown enforced by the government, numerous markets faced a great downfall while certain industries observed a booming growth during the period.

The Healthcare sector of all the regions and countries were overwhelmed and simultaneously witnessed a massive demand for different healthcare services. A number of recognized biopharmaceutical and pharmaceutical organizations as well as various synthetic biology centric companies contributed to researches across the world by offering synthetic biology expertise for building vaccines, test kits, and treatments to tackle the COVID-19 spread.

Market Growth Factors:


Rising efforts toward clinical researches to study biological systems

There is an increase in the efforts to conduct clinical researches with the aim to study the generated insights of the biological systems at the base of the molecular level. A biological system is a conceptual framework that is utilized by numerous researchers to further study the complicated biological processes. More researches in this field instigate an increase in the number of gene synthesis procedures. Researches associated with the biological system require a variety of studies respective to various aspects of DNA and gene synthesis.

Booming demand for personalized medicines

In the present scenario, a lot of people are undergoing distinct medication programs due to a variety of diseases. The medicines are produced with the purpose of generalized usage comprising various salts and other components. Regular medicines are distributed among people on the basis of the requirement of their treatment. The acids and salts along with other elements which are comprised in the generalized medicines do not suit everyone.

Marketing Restraining Factor:


Concerns regarding biosecurity, biosafety, and ethics

The number of researches in the field of gene synthesis is continuously increasing. The practices being performed during these researches involve different types of synthetic organisms. In addition, increasing researches and developments generate the risk of the outbreak of these synthetic organisms in the environment which could be a major challenge to biosafety concerns.



Method Outlook


Based on method, the gene synthesis market is classified into Chip-based, solid phase, and PCR-based Enzyme Synthesis. In 2020, the solid-phase gene synthesis segment held the biggest revenue share of the gene synthesis market. The solid phase refers to a traditional artificial gene production technique that displays a higher accuracy rate. In the solid-phase gene synthesis method, the molecules are engaged in an ionic bond on a solid surface named controlled porosity glass beads which are equipped with synthesis columns and individually synthesized.

Service Type Outlook


Based on service, the gene synthesis market is divided into Antibody DNA, Viral DNA, and Others. In 2020, the antibody DNA segment attained the highest revenue share of the gene synthesis market and is expected to continue to lead the market during the forecasting period. The growth of the segment is attributed to the rising number of companies destined to fulfill the significant demand for this antibody DNA service. The antibody DNA synthesis is conducted with restriction enzyme digestion which is followed by ligation and transformation or transfection.

Application Outlook


Based on application, the gene synthesis market is segmented into Gene & Cell Therapy Development, Vaccine Development, Disease Diagnosis, and Others. In 2020, the gene and cell therapy segment held the biggest revenue share of the gene synthesis market. In addition, the growth of this segment is a result of the increasing number of initiatives being taken for the development of gene and cell therapy. Gene therapy is the procedure of transmission of the genetic materials through a vector or a carrier and the delivery of the DNA to the appropriate cell.

End User Outlook


Based on End-user, the gene synthesis market is segregated into Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, Contract Research Organizations (CROs). In 2020, the academics and government research institutes segment procured the maximum revenue share of the market. This is credited to the rising preference of people for research settings for investigation and clinical research programs to conduct DNA synthesis practices. Also, the rising number of developments and discoveries in the biotechnology and pharmaceuticals is a factor that is responsible for increasing the number of new players in the market.

Regional Outlook


Based on region, the gene synthesis market is analyzed across North America, Europe, APAC, and LAMEA. In 2020, North America dominated the gene synthesis market by acquiring the highest revenue share of the market. North America is observing a constantly rising demand for development in gene synthesis applications for biopharmaceutical companies and academic institutes. Moreover, the increasing number of developments in medication based on gene synthesis therapy is also considered to accelerate the development of the market.

Cardinal Matrix - Gene Synthesis Market Competition Analysis




The major strategies followed by the market participants are Acquisitions and Partnerships. Based on the Analysis presented in the Thermo Fisher Scientific, Inc. is the major forerunner in the Gene Synthesis Market. Companies such as Danaher Corporation, Brooks Automation, Inc., Genscript Biotech Corporation are some of the key innovators in the Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Genscript Biotech Corporation, Thermo Fisher Scientific, Inc., Brooks Automation, Inc., Boster Biological Technology, Twist Bioscience Corporation, Danaher Corporation, Biomatik Corporation, ProteoGenix, ProMab Biotechnologies, Inc., and OriGene Technologies, Inc.

Recent Strategies Deployed in Gene Synthesis Market


» Partnerships, Collaborations and Agreements:

  • Aug-2021: GenScript teamed up with Allozymes, a synthetic biology firm. Following this collaboration, GenScript is expected to integrate its robust excellence in de novo gene synthesis capabilities along with its highly advanced semiconductor-based oligo synthesis technology into a patented screening platform of Allozymes intending to provide pinpoint control of every synthesized variant in order to attain an assorted and fully covered mutant range with the impartial distribution. Moreover, the companies is expected to focus on obtaining substantial breakthroughs in protein engineering research.
  • Aug-2021: Twist Bioscience joined hands with SomaLogic, a US-based protein biomarker discovery and clinical diagnostics company. Through this collaboration, the company aimed to innovate novel antibodies key disease biomarkers-based drug discovery. In addition, this collaboration is expected to allow Twist Biosciences to leverage the SomaScan platform of SomaLogic with the purpose of rapidly identifying antibodies against targets with the help of SomaLogic’s best-in-class 7,000-plex assay which is one of the broadest views of the proteome available.
  • Jun-2021: Twist Bioscience collaborated with Regeneron Genetics Center, a subsidiary of Regeneron. Through this collaboration, Twist Biosciences aimed to optimize the assay with content gathered from various cultures that enables increased characterization of various populations intending to enhance understanding across disease along with possible therapeutic development.
  • Jun-2021: Thermo Fisher Scientific collaborated with the University of Sheffield, a leading institution with a global reputation for research excellence. Through this collaboration, the companies aimed to develop cutting-edge end-to-end workflows for monitoring and characterizing complicated oligonucleotide and mRNA products. In addition, the collaboration is expected to integrate extensive research excellence of the University of Sheffield into advanced sample preparation, high-resolution accurate mass, liquid chromatography data interpretation software technologies, and mass spectrometry to allow the development of streamlined analytical workflows and robust fit-for-purpose processes.
  • Mar-2021: Twist Bioscience entered into a partnership with Watchmaker Genomics, a biotechnology company based in the US. Through this partnership, the companies aimed to provide distinct products that facilitate and streamline workflows before putting samples on the sequencer. Moreover, this partnership is expected to enable innovative research across a broad line of high throughput sequencing applications including inherited disease detection, minimal residual disease monitoring, liquid biopsy assays, and oncology and tumor profiling.
  • Oct-2020: Twist Bioscience partnered with Neogene Therapeutics, a biotechnology company. This partnership is expected to allow the company to accelerate genetic engineering and identification of TCR genes by integrating platforms of both companies with the purpose to innovate customized T cell therapies for cancer. Moreover, the companies aimed to break the barriers of limitations of currently available treatments
  • Jan-2020: GenScript entered into a partnership with Genopis, an expert in plasmid DNA-based technology and provider of contract development and manufacturing organization services. Under this partnership, GenScript is expected to leverage Genopis's manufacturing service of GMP Plasmids with the purpose to allow customers to reduce the cost and time of R&D. In addition, this partnership is expected to facilitate customers to efficiently diversify risks while leveraging resources in the early R&D phase.

» Acquisitions and Mergers:

  • Nov-2021: Twist Bioscience completed its acquisition of Abveris, a private in vivo antibody discovery services company. With this acquisition, the company aimed to enable its ability to pair natural, in vivo antibody development with its best-in-class humanization and engineering potentials intending to enrich antibody discovery with a new gold standard.
  • Jun-2021: Danaher acquired Aldevron, a US-based biotech company. Through this acquisition, the company aimed to strengthen its capabilities in genomic medicines and offer support to its vision of discovering more life-saving therapies and vaccines to market rapidly.
  • Mar-2021: Integrated DNA Technologies, a subsidiary of Danaher Corporation took over Swift Biosciences, a pioneer in the development of Next-Generation Sequencing (NGS) library preparation genomics kits. Under this acquisition, the company aimed to integrate Swift Biosciences' wide range of library preparation and enrichment products into its portfolio of high-quality NGS products intending to allow scientists to conduct more efficient research.
  • Jan-2021: Thermo Fisher Scientific acquired Henogen, a Belgium-based viral vector manufacturing subsidiary of Novasep. Following this acquisition, the company is expected to leverage Novasep's capabilities to expand its portfolio of cell and gene vaccines and therapies globally. Moreover, this acquisition is expected to allow the company to benefit its global customers seeking support and capacity in the region while bringing new medicines for patients in or outside of Europe.

» Product Launches and Product Expansions:

  • Nov-2021: GenScript USA rolled out GenWand, a Double-Stranded DNA service. Through this launch, the company aimed to offer enhanced efficiency along with reduced toxicity to the manufacturers of CRISPR knock-in homology-directed repair (HDR) templates in T cell engineering while performing gene knock-in. Additionally, the new GenWand is an ideal solution for large-scale screening and scale-up in cell and gene therapy.
  • Oct-2021: Twist Bioscience rolled out its Exome 2.0, featuring complete analysis of protein-coding and non-coding regions of the genome while reducing downstream costs. Through this launch, the company aimed to offer an all-inclusive range of flexible and comprehensive exome options intending to assist genomics researchers seeking to find out the origins of disease.
  • Dec-2020: Twist Bioscience released Clonal-Ready Gene Fragments, the best-in-class Gene Fragments of the company. Through this launch, the company aimed to offer a complete range of genes to its customers. In addition, the new Clonal-Ready Gene Fragments can be used with or without adapters to build structures in reduced time and cost of screening for perfect clones.
  • Jun-2020: Integrated DNA Technologies, a subsidiary of Danaher Corporation rolled out gBlocks, HiFi Gene Fragments. Through this launch, the company aimed to offer a high-quality product with consistent fidelity to researchers intending to facilitate the building of large gene structures and eliminate the risk of unwanted mutations in their sequences. Moreover, it is expected to allow researchers to choose 50% fewer colonies to locate their gene or pathway of interest while reducing time and money.

» Geographical Expansions:

  • Nov-2021: GenScript expanded its global footprint by opening a new gene synthesis facility in the USA. Through this geographical expansion, the company aimed to establish a robust synthesis facility with expanded capabilities of synthesizing 4000-5000 genes in a month. In addition, it is expected to also reduce the company's concern for legal constraints on the import of genes that are synthesized outside of the domestic territory of the USA along with supply chain errors and accelerate the delivery as well.
  • Dec-2020: Twist Bioscience expanded its geographical footprint by opening the Factory of the Future in Oregon, Wilsonville. This geographical expansion is expected to allow the company to fulfill the rising demand of its customers as they measure globally and plan for competitive growth in synthetic biology and biopharma segments of the market.
  • Sep-2020: Integrated DNA Technologies, a subsidiary of Danaher Corporation expanded its geographical footprint by launching IDT China. Through this expansion, the company aimed to strengthen its service for customers across the country. Moreover, this expansion is expected to allow the company to expand its reach to new customers along with facilitating access to its line of cutting-edge products.

Scope of the Study


Market Segments Covered in the Report:


By Method

  • Solid-phase Synthesis
  • Chip-based Synthesis and
  • PCR-based Enzyme Synthesis

By Service Type

  • Antibody DNA Synthesis
  • Viral DNA Synthesis and
  • Others

By Application

  • Gene & Cell Therapy Development
  • Vaccine Development
  • Disease Diagnosis and
  • Others

By End User

  • Academic & Government Research Institutes
  • Biotechnology & Pharmaceutical Companies and
  • Contract Research Organizations

By Geography


  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players


List of Companies Profiled in the Report:

  • Genscript Biotech Corporation
  • Thermo Fisher Scientific, Inc.
  • Brooks Automation, Inc.
  • Boster Biological Technology
  • Twist Bioscience Corporation
  • Danaher Corporation
  • Biomatik Corporation
  • ProteoGenix
  • ProMab Biotechnologies, Inc.
  • OriGene Technologies, Inc.

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Gene Synthesis Market, by Method
1.4.2 Global Gene Synthesis Market, by Service Type
1.4.3 Global Gene Synthesis Market, by Application
1.4.4 Global Gene Synthesis Market, by End User
1.4.5 Global Gene Synthesis Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Acquisition and Mergers
3.2.2 Partnerships, Collaborations and Agreements
3.2.3 Product Launches and Product Expansions
3.2.4 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2017, Dec - 2021, Nov) Leading Players
3.3.3 Key Strategic Move: (Partnerships, Collaborations, and Agreements 2017, Jul - 2021, Aug) Leading Players
Chapter 4. Global Gene Synthesis Market by Method
4.1 Global Solid-phase Synthesis Market by Region
4.2 Global Chip-based Synthesis Market by Region
4.3 Global PCR-based Enzyme Synthesis Market by Region
Chapter 5. Global Gene Synthesis Market by Service Type
5.1 Global Antibody DNA Synthesis Market by Region
5.2 Global Viral DNA Synthesis Market by Region
5.3 Global Others Market by Region
Chapter 6. Global Gene Synthesis Market by Application
6.1 Global Gene & Cell Therapy Development Market by Region
6.2 Global Vaccine Development Market by Region
6.3 Global Disease Diagnosis Market by Region
6.4 Global Others Market by Region
Chapter 7. Global Gene Synthesis Market by End User
7.1 Global Academic & Government Research Institutes Market by Region
7.2 Global Biotechnology & Pharmaceutical Companies Market by Region
7.3 Global Contract Research Organizations Market by Region
Chapter 8. Global Gene Synthesis Market by Region
8.1 North America Gene Synthesis Market
8.1.1 North America Gene Synthesis Market by Method
8.1.1.1 North America Solid-phase Synthesis Market by Country
8.1.1.2 North America Chip-based Synthesis Market by Country
8.1.1.3 North America PCR-based Enzyme Synthesis Market by Country
8.1.2 North America Gene Synthesis Market by Service Type
8.1.2.1 North America Antibody DNA Synthesis Market by Country
8.1.2.2 North America Viral DNA Synthesis Market by Country
8.1.2.3 North America Others Market by Country
8.1.3 North America Gene Synthesis Market by Application
8.1.3.1 North America Gene & Cell Therapy Development Market by Country
8.1.3.2 North America Vaccine Development Market by Country
8.1.3.3 North America Disease Diagnosis Market by Country
8.1.3.4 North America Others Market by Country
8.1.4 North America Gene Synthesis Market by End User
8.1.4.1 North America Academic & Government Research Institutes Market by Country
8.1.4.2 North America Biotechnology & Pharmaceutical Companies Market by Country
8.1.4.3 North America Contract Research Organizations Market by Country
8.1.5 North America Gene Synthesis Market by Country
8.1.5.1 US Gene Synthesis Market
8.1.5.1.1 US Gene Synthesis Market by Method
8.1.5.1.2 US Gene Synthesis Market by Service Type
8.1.5.1.3 US Gene Synthesis Market by Application
8.1.5.1.4 US Gene Synthesis Market by End User
8.1.5.2 Canada Gene Synthesis Market
8.1.5.2.1 Canada Gene Synthesis Market by Method
8.1.5.2.2 Canada Gene Synthesis Market by Service Type
8.1.5.2.3 Canada Gene Synthesis Market by Application
8.1.5.2.4 Canada Gene Synthesis Market by End User
8.1.5.3 Mexico Gene Synthesis Market
8.1.5.3.1 Mexico Gene Synthesis Market by Method
8.1.5.3.2 Mexico Gene Synthesis Market by Service Type
8.1.5.3.3 Mexico Gene Synthesis Market by Application
8.1.5.3.4 Mexico Gene Synthesis Market by End User
8.1.5.4 Rest of North America Gene Synthesis Market
8.1.5.4.1 Rest of North America Gene Synthesis Market by Method
8.1.5.4.2 Rest of North America Gene Synthesis Market by Service Type
8.1.5.4.3 Rest of North America Gene Synthesis Market by Application
8.1.5.4.4 Rest of North America Gene Synthesis Market by End User
8.2 Europe Gene Synthesis Market
8.2.1 Europe Gene Synthesis Market by Method
8.2.1.1 Europe Solid-phase Synthesis Market by Country
8.2.1.2 Europe Chip-based Synthesis Market by Country
8.2.1.3 Europe PCR-based Enzyme Synthesis Market by Country
8.2.2 Europe Gene Synthesis Market by Service Type
8.2.2.1 Europe Antibody DNA Synthesis Market by Country
8.2.2.2 Europe Viral DNA Synthesis Market by Country
8.2.2.3 Europe Others Market by Country
8.2.3 Europe Gene Synthesis Market by Application
8.2.3.1 Europe Gene & Cell Therapy Development Market by Country
8.2.3.2 Europe Vaccine Development Market by Country
8.2.3.3 Europe Disease Diagnosis Market by Country
8.2.3.4 Europe Others Market by Country
8.2.4 Europe Gene Synthesis Market by End User
8.2.4.1 Europe Academic & Government Research Institutes Market by Country
8.2.4.2 Europe Biotechnology & Pharmaceutical Companies Market by Country
8.2.4.3 Europe Contract Research Organizations Market by Country
8.2.5 Europe Gene Synthesis Market by Country
8.2.5.1 Germany Gene Synthesis Market
8.2.5.1.1 Germany Gene Synthesis Market by Method
8.2.5.1.2 Germany Gene Synthesis Market by Service Type
8.2.5.1.3 Germany Gene Synthesis Market by Application
8.2.5.1.4 Germany Gene Synthesis Market by End User
8.2.5.2 UK Gene Synthesis Market
8.2.5.2.1 UK Gene Synthesis Market by Method
8.2.5.2.2 UK Gene Synthesis Market by Service Type
8.2.5.2.3 UK Gene Synthesis Market by Application
8.2.5.2.4 UK Gene Synthesis Market by End User
8.2.5.3 France Gene Synthesis Market
8.2.5.3.1 France Gene Synthesis Market by Method
8.2.5.3.2 France Gene Synthesis Market by Service Type
8.2.5.3.3 France Gene Synthesis Market by Application
8.2.5.3.4 France Gene Synthesis Market by End User
8.2.5.4 Russia Gene Synthesis Market
8.2.5.4.1 Russia Gene Synthesis Market by Method
8.2.5.4.2 Russia Gene Synthesis Market by Service Type
8.2.5.4.3 Russia Gene Synthesis Market by Application
8.2.5.4.4 Russia Gene Synthesis Market by End User
8.2.5.5 Spain Gene Synthesis Market
8.2.5.5.1 Spain Gene Synthesis Market by Method
8.2.5.5.2 Spain Gene Synthesis Market by Service Type
8.2.5.5.3 Spain Gene Synthesis Market by Application
8.2.5.5.4 Spain Gene Synthesis Market by End User
8.2.5.6 Italy Gene Synthesis Market
8.2.5.6.1 Italy Gene Synthesis Market by Method
8.2.5.6.2 Italy Gene Synthesis Market by Service Type
8.2.5.6.3 Italy Gene Synthesis Market by Application
8.2.5.6.4 Italy Gene Synthesis Market by End User
8.2.5.7 Rest of Europe Gene Synthesis Market
8.2.5.7.1 Rest of Europe Gene Synthesis Market by Method
8.2.5.7.2 Rest of Europe Gene Synthesis Market by Service Type
8.2.5.7.3 Rest of Europe Gene Synthesis Market by Application
8.2.5.7.4 Rest of Europe Gene Synthesis Market by End User
8.3 Asia Pacific Gene Synthesis Market
8.3.1 Asia Pacific Gene Synthesis Market by Method
8.3.1.1 Asia Pacific Solid-phase Synthesis Market by Country
8.3.1.2 Asia Pacific Chip-based Synthesis Market by Country
8.3.1.3 Asia Pacific PCR-based Enzyme Synthesis Market by Country
8.3.2 Asia Pacific Gene Synthesis Market by Service Type
8.3.2.1 Asia Pacific Antibody DNA Synthesis Market by Country
8.3.2.2 Asia Pacific Viral DNA Synthesis Market by Country
8.3.2.3 Asia Pacific Others Market by Country
8.3.3 Asia Pacific Gene Synthesis Market by Application
8.3.3.1 Asia Pacific Gene & Cell Therapy Development Market by Country
8.3.3.2 Asia Pacific Vaccine Development Market by Country
8.3.3.3 Asia Pacific Disease Diagnosis Market by Country
8.3.3.4 Asia Pacific Others Market by Country
8.3.4 Asia Pacific Gene Synthesis Market by End User
8.3.4.1 Asia Pacific Academic & Government Research Institutes Market by Country
8.3.4.2 Asia Pacific Biotechnology & Pharmaceutical Companies Market by Country
8.3.4.3 Asia Pacific Contract Research Organizations Market by Country
8.3.5 Asia Pacific Gene Synthesis Market by Country
8.3.5.1 China Gene Synthesis Market
8.3.5.1.1 China Gene Synthesis Market by Method
8.3.5.1.2 China Gene Synthesis Market by Service Type
8.3.5.1.3 China Gene Synthesis Market by Application
8.3.5.1.4 China Gene Synthesis Market by End User
8.3.5.2 Japan Gene Synthesis Market
8.3.5.2.1 Japan Gene Synthesis Market by Method
8.3.5.2.2 Japan Gene Synthesis Market by Service Type
8.3.5.2.3 Japan Gene Synthesis Market by Application
8.3.5.2.4 Japan Gene Synthesis Market by End User
8.3.5.3 India Gene Synthesis Market
8.3.5.3.1 India Gene Synthesis Market by Method
8.3.5.3.2 India Gene Synthesis Market by Service Type
8.3.5.3.3 India Gene Synthesis Market by Application
8.3.5.3.4 India Gene Synthesis Market by End User
8.3.5.4 South Korea Gene Synthesis Market
8.3.5.4.1 South Korea Gene Synthesis Market by Method
8.3.5.4.2 South Korea Gene Synthesis Market by Service Type
8.3.5.4.3 South Korea Gene Synthesis Market by Application
8.3.5.4.4 South Korea Gene Synthesis Market by End User
8.3.5.5 Singapore Gene Synthesis Market
8.3.5.5.1 Singapore Gene Synthesis Market by Method
8.3.5.5.2 Singapore Gene Synthesis Market by Service Type
8.3.5.5.3 Singapore Gene Synthesis Market by Application
8.3.5.5.4 Singapore Gene Synthesis Market by End User
8.3.5.6 Malaysia Gene Synthesis Market
8.3.5.6.1 Malaysia Gene Synthesis Market by Method
8.3.5.6.2 Malaysia Gene Synthesis Market by Service Type
8.3.5.6.3 Malaysia Gene Synthesis Market by Application
8.3.5.6.4 Malaysia Gene Synthesis Market by End User
8.3.5.7 Rest of Asia Pacific Gene Synthesis Market
8.3.5.7.1 Rest of Asia Pacific Gene Synthesis Market by Method
8.3.5.7.2 Rest of Asia Pacific Gene Synthesis Market by Service Type
8.3.5.7.3 Rest of Asia Pacific Gene Synthesis Market by Application
8.3.5.7.4 Rest of Asia Pacific Gene Synthesis Market by End User
8.4 LAMEA Gene Synthesis Market
8.4.1 LAMEA Gene Synthesis Market by Method
8.4.1.1 LAMEA Solid-phase Synthesis Market by Country
8.4.1.1.1 LAMEA Chip-based Synthesis Market by Country
8.4.1.1.2 LAMEA PCR-based Enzyme Synthesis Market by Country
8.4.1.2 LAMEA Gene Synthesis Market by Service Type
8.4.1.2.1 LAMEA Antibody DNA Synthesis Market by Country
8.4.1.2.2 LAMEA Viral DNA Synthesis Market by Country
8.4.1.2.3 LAMEA Others Market by Country
8.4.2 LAMEA Gene Synthesis Market by Application
8.4.2.1 LAMEA Gene & Cell Therapy Development Market by Country
8.4.2.2 LAMEA Vaccine Development Market by Country
8.4.2.3 LAMEA Disease Diagnosis Market by Country
8.4.2.4 LAMEA Others Market by Country
8.4.3 LAMEA Gene Synthesis Market by End User
8.4.3.1 LAMEA Academic & Government Research Institutes Market by Country
8.4.3.2 LAMEA Biotechnology & Pharmaceutical Companies Market by Country
8.4.3.3 LAMEA Contract Research Organizations Market by Country
8.4.4 LAMEA Gene Synthesis Market by Country
8.4.4.1 Brazil Gene Synthesis Market
8.4.4.1.1 Brazil Gene Synthesis Market by Method
8.4.4.1.2 Brazil Gene Synthesis Market by Service Type
8.4.4.1.3 Brazil Gene Synthesis Market by Application
8.4.4.1.4 Brazil Gene Synthesis Market by End User
8.4.4.2 Argentina Gene Synthesis Market
8.4.4.2.1 Argentina Gene Synthesis Market by Method
8.4.4.2.2 Argentina Gene Synthesis Market by Service Type
8.4.4.2.3 Argentina Gene Synthesis Market by Application
8.4.4.2.4 Argentina Gene Synthesis Market by End User
8.4.4.3 UAE Gene Synthesis Market
8.4.4.3.1 UAE Gene Synthesis Market by Method
8.4.4.3.2 UAE Gene Synthesis Market by Service Type
8.4.4.3.3 UAE Gene Synthesis Market by Application
8.4.4.3.4 UAE Gene Synthesis Market by End User
8.4.4.4 Saudi Arabia Gene Synthesis Market
8.4.4.4.1 Saudi Arabia Gene Synthesis Market by Method
8.4.4.4.2 Saudi Arabia Gene Synthesis Market by Service Type
8.4.4.4.3 Saudi Arabia Gene Synthesis Market by Application
8.4.4.4.4 Saudi Arabia Gene Synthesis Market by End User
8.4.4.5 South Africa Gene Synthesis Market
8.4.4.5.1 South Africa Gene Synthesis Market by Method
8.4.4.5.2 South Africa Gene Synthesis Market by Service Type
8.4.4.5.3 South Africa Gene Synthesis Market by Application
8.4.4.5.4 South Africa Gene Synthesis Market by End User
8.4.4.6 Nigeria Gene Synthesis Market
8.4.4.6.1 Nigeria Gene Synthesis Market by Method
8.4.4.6.2 Nigeria Gene Synthesis Market by Service Type
8.4.4.6.3 Nigeria Gene Synthesis Market by Application
8.4.4.6.4 Nigeria Gene Synthesis Market by End User
8.4.4.7 Rest of LAMEA Gene Synthesis Market
8.4.4.7.1 Rest of LAMEA Gene Synthesis Market by Method
8.4.4.7.2 Rest of LAMEA Gene Synthesis Market by Service Type
8.4.4.7.3 Rest of LAMEA Gene Synthesis Market by Application
8.4.4.7.4 Rest of LAMEA Gene Synthesis Market by End User
Chapter 9. Company Profiles
9.1 Genscript Biotech Corporation
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional & Segmental Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments
9.1.5.1 Partnerships, Collaborations, and Agreements
9.1.5.2 Product Launches and Product Expansions
9.1.5.3 Acquisition and Mergers:
9.1.5.4 Geographical Expansions
9.2 Thermo Fisher Scientific, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments
9.2.5.1 Partnerships, Collaborations, and Agreements
9.2.5.2 Acquisition and Mergers:
9.2.5.3 Geographical Expansions
9.2.6 SWOT Analysis
9.3 Brooks Automation, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional & Segmental Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments
9.3.5.1 Acquisition and Mergers:
9.4 Boster Biological Technology
9.4.1 Company Overview
9.5 Twist Bioscience Corporation
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional & Segmental Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments
9.5.5.1 Partnerships, Collaborations, and Agreements
9.5.5.2 Acquisition and Mergers:
9.5.5.3 Product Launches and Product Expansions
9.5.5.4 Geographical Expansions
9.6 Danaher Corporation
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments
9.6.5.1 Product Launches and Product Expansions
9.6.5.2 Acquisition and Mergers:
9.6.5.3 Geographical Expansions
9.7 Biomatik Corporation
9.7.1 Company Overview
9.8 ProteoGenix
9.8.1 Company Overview
9.9 ProMab Biotechnologies, Inc.
9.9.1 Company Overview
9.10. OriGene Technologies, Inc.
9.10.1 Company Overview.

Companies Mentioned

  • Genscript Biotech Corporation
  • Thermo Fisher Scientific, Inc.
  • Brooks Automation, Inc.
  • Boster Biological Technology
  • Twist Bioscience Corporation
  • Danaher Corporation
  • Biomatik Corporation
  • ProteoGenix
  • ProMab Biotechnologies, Inc.
  • OriGene Technologies, Inc.

Methodology

Loading
LOADING...